Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2026 Q1 | Apr 1, 2026 | Protean Small Cap | - | - | BALD-B.ST, CINT.ST, DEVYSER.ST, NIBE-B.ST, RUSTA.ST, VERTI.ST | active management, Energy Transition, Geopolitical, Heat Pumps, Nordics, small caps, volatility | VERT VIMIAN.ST DEVYSER.ST CINT.ST NIBE IN |
View | |
| 2025 Q3 | Oct 1, 2025 | Protean Select | - | 6.7% | ARJO-B.ST, BALD-B.ST, BOULE.ST, CHMO.CO, COLO-B.CO, DEMANT.CO, DEVYSER.ST, EAST.ST, EKTA-B.ST, ELUX-B.ST, GETI-B.ST, GRNGS.ST, HM-B.ST, INDU-A.ST, LUMI.ST, LUN.CO, MTG-B.ST, NIMB.ST, RUSTA.ST, SDIP.ST, SINCH.ST, SKA-B.ST, SWED-A.ST, VIM.ST, VITRO.ST | active management, Medtech, Nordics, Quality, SmallCap, value | Protean stresses the importance of active, adaptive positioning in sideways and volatile markets. The fund seeks incremental gains through tactical adjustments, pair trades, and valuation sensitivity. Active management remains valuable as dispersion and uncertainty rise. | View | |
| 2025 Q3 | Oct 1, 2025 | Protean Small Cap | - | 11.8% | ARJO-B.ST, ASSA-B.ST, BALD-B.ST, BOUL.ST, CHMO.CO, COLO-B.ST, DEMANT.CO, DEVYSER.ST, EAST.ST, EKTA-B.ST, ELUX-B.ST, GETI-B.ST, GRNGS.ST, HM-B.ST, INDU-A.ST, INVE-B.ST, LUMI.ST, LUN-B.ST, MTG-B.ST, NESTE.HE, NIMB.ST, RUSTA.ST, SDIP.ST, SINCH.ST, SKA-B.ST, SWED-A.ST, VIMIAN.ST, VITR.ST | active management, Medtech, Nordic, Quality, small cap, value | The letter highlights inefficiencies in Nordic small caps where nimble funds can exploit mispricings. Protean emphasizes valuation sensitivity, active trading, and selective risk-taking. Small caps remain attractive as dispersion widens and larger funds lose flexibility. | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | Fund Letters | Protean Small Cap | Devyser Diagnostics AB | Other | Life Sciences Tools & Services | Bull | New York Stock Exchange | Cash Flow Breakeven, contrarian, Disease Detection, DNA Analysis, Genetic Testing, Healthcare Diagnostics, Healthcare Technology, Sticky Protocols | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||